Xtant Medical Approves Equity Plan Amendment at Meeting

Tip Ranks
2025.11.10 12:35
portai
I'm PortAI, I can summarize articles.

Xtant Medical Holdings approved an amendment to its 2023 Equity Incentive Plan at its annual stockholders meeting on November 7, 2025, increasing shares by 12,300,000. The meeting also included the election of directors and the ratification of Grant Thornton LLP as the accounting firm. Analyst ratings for XTNT stock are currently a Hold with a $1.00 price target, reflecting strong revenue growth but challenges in financial performance. The company specializes in regenerative medicine products, particularly in orthopedics and spine.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Xtant Medical Holdings ( (XTNT) ) has issued an announcement.

On November 7, 2025, Xtant Medical Holdings held its annual stockholders meeting, where an amendment to the 2023 Equity Incentive Plan was approved, increasing the number of shares by 12,300,000. This decision, alongside other proposals such as the election of directors and the ratification of Grant Thornton LLP as the accounting firm, reflects the company’s strategic moves to enhance its operational framework and shareholder engagement.

The most recent analyst rating on (XTNT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Xtant Medical Holdings stock, see the XTNT Stock Forecast page.

Spark’s Take on XTNT Stock

According to Spark, TipRanks’ AI Analyst, XTNT is a Neutral.

Xtant Medical Holdings’ overall score is driven by strong earnings call results, indicating significant revenue growth and improved profitability. However, financial performance challenges and a weak valuation score due to negative P/E ratio weigh down the overall score. Technical analysis provides a positive outlook with strong market momentum.

To see Spark’s full report on XTNT stock, click here.

More about Xtant Medical Holdings

Xtant Medical Holdings, Inc. operates in the medical industry, focusing on providing regenerative medicine products and services. The company specializes in the development and distribution of orthopedic and spine products, catering to healthcare providers and patients in need of advanced medical solutions.

Average Trading Volume: 202,988

Technical Sentiment Signal: Buy

Current Market Cap: $105.4M

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer